Where does Miramar Labs, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Miramar Labs, Inc. ranks #41,716 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Miramar Labs, Inc. hold?

Miramar Labs, Inc. holds 6 US utility patents granted between 2015 and 2016, spanning 3 technology areas.

What is Miramar Labs, Inc.'s Innovation Score?

Miramar Labs, Inc. has an Innovation Score of 18.9 out of 100 (5th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Miramar Labs, Inc. focus on?

Miramar Labs, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 6 patents, ranking #2,680 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Miramar Labs, Inc.'s patent grant rate increasing or decreasing?

Miramar Labs, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Miramar Labs, Inc.'s patents?

Miramar Labs, Inc.'s patents average 10.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Miramar Labs, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Miramar Labs, Inc.

USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2015–2016. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Miramar ranks #41,716 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.

#41,716
of 49,997 US assignees by volume: 5th percentile
by Innovation Score (18.9/100): 10.2
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R41716 · US Corporation #41,716 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #41,716/49,997
PHOTO-FINISH Mimetogen Pharmaceut…
CPC-NARROW A61B · 3 areas
INNOV-LOW 18.9/100
CLAIMS-PAR 10.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mimetogen Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Miramar’s 18.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (35%) Velocity 0.0 pts (0%) Breadth 6.1 pts (32%) Claim depth 6.1 pts (32%)

Qualcomm Incorporated · highest

85
Mizuno USA · near

19
Miramar Labs · this assignee

19
Holton Products · near

19
Quarsa · near

19
Phoenix Conveyor… · near

19
3D Lighting… · lowest

7

What this shows Miramar's Innovation Score is 18.9/100 (5th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Miramar?

Each dot is one of Miramar’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Miramar’s own 10.2 claims/patent is at or below the 18.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Miramar vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Miramar's grants concentrate

Miramar Labs, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Miramar sits between Mimetogen Pharmaceuticals, Inc. and Mississippi International Water Inc..

Mimetogen Pharmac…

6
Minicare B V

6
Mips

6
Miraclon

6
Miri Systems

6
Mirion

6
Mission Pharmacal

6
Mississippi Inter…

6
Miramar Labs ◀

6

What this shows Miramar holds 6 patents at rank #41,597, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Miramar

By rank, the assignees closest to #41,597 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Miramar's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Miramar, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Miramar ranks #2,680 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (19 here).

Holton Products LLC 19 Mizuno USA, Inc. 19 Quarsa, LLC 19 Phoenix Conveyor Belt Systems GmbH 19

Miramar's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

19 5th percentile higher than 5% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2016

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Miramar Labs, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	50.0%
2016	3	50.0%

Which technologies does Miramar Labs, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Miramar Labs, Inc.'s patent record in context - here's where to go next.

Miramar Labs, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #41,716 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Miramar Labs, Inc. against Mimetogen Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 18.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.